AI assistant
Sending…
PDS Biotechnology Corp — Director's Dealing 2017
Nov 22, 2017
34613_dirs_2017-11-22_3b954fd3-82fe-4cfe-b830-2e7560546593.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edge Therapeutics, Inc. (EDGE)
CIK: 0001472091
Period of Report: 2017-11-22
Reporting Person: MARCHIO ALBERT N II (Chief Accounting & Adm Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-22 | Common Stock | S | 3361 | $10.00 | Disposed | 0 | Direct |
More from PDS Biotechnology Corp
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 1
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Mar 30
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3